Skip to main content
Premium Trial:

Request an Annual Quote

Invivoscribe CE-IVD LymphoTrack Dx Assays

Invivoscribe Technologies has launched three new CE-marked in vitro diagnostic assays for the company's Ion PGM Dx System. The new assays include an IGH, IGK, and TRG clonality assays to aid in the diagnosis of B-cell malignancies. When the IGH and IGK assays are used together, it's possible to detect clonality in a majority of B-cell malignancies with nearly 100 percent clinical sensitivity, the company said. Additionally, when all three assays are used together, it is possible to detect a least one clonal biomarker target in the vast majority of hematologic malignancies, the company said.

The Scan

Panel Recommends Pfizer-BioNTech Vaccine for Kids

CNN reports that the US Food and Drug Administration advisory panel has voted in favor of authorizing the Pfizer-BioNTech SARS-CoV-2 vaccine for children between 5 and 11 years old.

Sharing How to Make It

Merck had granted a royalty-free license for its COVID-19 treatment to the Medicines Patent Pool, according to the New York Times.

Bring it Back In

Bloomberg reports that a genetic analysis has tied a cluster of melioidosis cases in the US to a now-recalled aromatherapy spray.

Nucleic Acids Research Papers on SomaMutDB, VThunter, SCovid Databases

In Nucleic Acids Research this week: database of somatic mutations in normal tissue, viral receptor-related expression signatures, and more.